Manchester Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,404
| Closed | -$1.03M | – | 552 |
|
|
2019
Q3 | $1.03M | Buy |
10,404
+636
| +7% | +$60.4K | 0.12% | 90 |
|
|
2019
Q2 | $903K | Hold |
9,768
| – | – | 0.12% | 101 |
|
|
2019
Q1 | $922K | Buy |
9,768
+120
| +1% | +$10.5K | 0.12% | 92 |
|
|
2018
Q4 | $766K | Hold |
9,648
| – | – | 0.12% | 103 |
|
|
2018
Q3 | $863K | Hold |
9,648
| – | – | 0.12% | 89 |
|
|
2018
Q2 | $766K | Buy |
9,648
+8,422
| +687% | +$699K | 0.12% | 104 |
|
|
2018
Q1 | $109K | Buy |
1,226
+38
| +3% | +$3.65K | 0.02% | 268 |
|
|
2017
Q4 | $124K | Hold |
1,188
| – | – | 0.02% | 241 |
|
|
2017
Q3 | $173K | Hold |
1,188
| – | – | 0.03% | 198 |
|
|
2017
Q2 | $154K | Hold |
1,188
| – | – | 0.02% | 217 |
|
|
2017
Q1 | $148K | Hold |
1,188
| – | – | 0.02% | 221 |
|
|
2016
Q4 | $138K | Hold |
1,188
| – | – | 0.02% | 227 |
|
|
2016
Q3 | $124K | Sell |
1,188
-1,312
| -52% | -$142K | 0.02% | 246 |
|
|
2016
Q2 | $247K | Hold |
2,500
| – | – | 0.04% | 171 |
|
|
2016
Q1 | $250K | Hold |
2,500
| – | – | 0.03% | 175 |
|
|
2015
Q4 | $299K | Hold |
2,500
| – | – | 0.04% | 170 |
|
|
2015
Q3 | $270K | Hold |
2,500
| – | – | 0.05% | 162 |
|
|
2015
Q2 | $289K | Hold |
2,500
| – | – | 0.05% | 169 |
|
|
2015
Q1 | $288K | Sell |
2,500
-926
| -27% | -$111K | 0.05% | 166 |
|
|
2014
Q4 | $383K | Hold |
3,426
| – | – | 0.05% | 212 |
|
|
2014
Q3 | $325K | Hold |
3,426
| – | – | 0.04% | 228 |
|
|
2014
Q2 | $294K | Hold |
3,426
| – | – | 0.04% | 275 |
|
|
2014
Q1 | $239K | Sell |
3,426
-20
| -0.6% | -$1.58K | 0.04% | 293 |
|
|
2013
Q4 | $291K | Hold |
3,446
| – | – | 0.05% | 253 |
|
|
2013
Q3 | $266K | Sell |
3,446
-208
| -6% | -$14.6K | 0.05% | 272 |
|
|
2013
Q2 | $214K | Buy |
+3,654
| New | +$220K | 0.04% | 292 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Manchester Capital Management's CELG Position: Q4 2019 in Review
Manchester Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,404 shares — an estimated $1.03M sold.
Manchester Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.03M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Manchester Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Manchester Capital Management sold 10,404 Celgene Corp shares in Q4 2019, an estimated $1.03M.
- Manchester Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Manchester Capital Management's Celgene Corp position peaked at $1.03M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Manchester Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.